These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33529752)
1. Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain. Borgonetti V; Galeotti N Pharmacol Res; 2021 Mar; 165():105431. PubMed ID: 33529752 [TBL] [Abstract][Full Text] [Related]
2. Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury. Borgonetti V; Meacci E; Pierucci F; Romanelli MN; Galeotti N Neurotherapeutics; 2022 Sep; 19(5):1634-1648. PubMed ID: 35501470 [TBL] [Abstract][Full Text] [Related]
4. Nerve Excitability and Neuropathic Pain is Reduced by BET Protein Inhibition After Spared Nerve Injury. Palomés-Borrajo G; Badia J; Navarro X; Penas C J Pain; 2021 Dec; 22(12):1617-1630. PubMed ID: 34157407 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins. Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs. Zhang W; Jiao B; Yu S; Zhang C; Zhang K; Liu B; Zhang X CNS Neurosci Ther; 2024 May; 30(5):e14745. PubMed ID: 38715326 [TBL] [Abstract][Full Text] [Related]
7. Valproic acid mitigates spinal nerve ligation-induced neuropathic pain in rats by modulating microglial function and inhibiting neuroinflammatory response. Guo A; Li J; Luo L; Chen C; Lu Q; Ke J; Feng X Int Immunopharmacol; 2021 Mar; 92():107332. PubMed ID: 33421931 [TBL] [Abstract][Full Text] [Related]
8. The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse model. Sanna MD; Guandalini L; Romanelli MN; Galeotti N Pharmacol Biochem Behav; 2017 Sep; 160():70-75. PubMed ID: 28821396 [TBL] [Abstract][Full Text] [Related]
9. BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury. Sánchez-Ventura J; Amo-Aparicio J; Navarro X; Penas C J Neuroinflammation; 2019 Jun; 16(1):124. PubMed ID: 31186006 [TBL] [Abstract][Full Text] [Related]
10. The HDAC1/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling. Sanna MD; Galeotti N Eur J Pharmacol; 2018 Apr; 825():99-106. PubMed ID: 29477655 [TBL] [Abstract][Full Text] [Related]
11. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target]. Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Bai G; Wei D; Zou S; Ren K; Dubner R Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541 [TBL] [Abstract][Full Text] [Related]
14. Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice. Borgonetti V; Governa P; Biagi M; Pellati F; Galeotti N Phytomedicine; 2020 Nov; 78():153307. PubMed ID: 32846405 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain. Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288 [TBL] [Abstract][Full Text] [Related]
16. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
17. Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition. Rajendran P; Johnson G; Li L; Chen YS; Dashwood M; Nguyen N; Ulusan A; Ertem F; Zhang M; Li J; Sun D; Huang Y; Wang S; Leung HC; Lieberman D; Beaver L; Ho E; Bedford M; Chang K; Vilar E; Dashwood R Cancer Res; 2019 Mar; 79(5):918-927. PubMed ID: 30643017 [TBL] [Abstract][Full Text] [Related]
19. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446 [TBL] [Abstract][Full Text] [Related]
20. BET Bromodomain as a Target of Epigenetic Therapy. Noguchi-Yachide T Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]